Adult rheumatologic features, treatment and complications of X-linked hypophosphatemia

Arch Pediatr. 2021 Oct;28(7):606-611. doi: 10.1016/j.arcped.2021.09.004. Epub 2021 Oct 6.

Abstract

X-linked hypophosphatemia (XLH) is a rare genetic phosphate disorder caused mainly by PHEX mutations. Unlike for children, knowledge of the disease's manifestations in adults is limited. Musculoskeletal symptoms are the main feature of the disease in young adults associated with a heavy burden on patients' life. They include fractures and pseudofractures, pain, joint stiffness, osteoarthritis, enthesopathies, and muscle weakness, eventually leading to impaired quality of life. Conventional treatment with phosphate supplements and vitamin D analogs is indicated in symptomatic patients. Appropriate rehabilitation is also a key to the management of the disease to improve physical function and decrease pain, stiffness, and fatigue. Regarding the incidence and consequences of musculoskeletal features in XLH, all patients should be assessed by a bone disease specialist and, if necessary, managed by a multidisciplinary team.

Keywords: Enthesopathies; Fatigue; Hypophosphatemic rickets; Osteoarthritis; Rheumatologic features; Stiffness; X-linked hypophosphatemia.

MeSH terms

  • Enthesopathy / etiology
  • Enthesopathy / physiopathology
  • Familial Hypophosphatemic Rickets / complications*
  • Familial Hypophosphatemic Rickets / physiopathology
  • Familial Hypophosphatemic Rickets / therapy*
  • Humans
  • Mutation / genetics
  • Osteoarthritis / etiology
  • Osteoarthritis / physiopathology
  • PHEX Phosphate Regulating Neutral Endopeptidase / genetics

Substances

  • PHEX Phosphate Regulating Neutral Endopeptidase
  • PHEX protein, human